Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Eli Lilly and Company (LLY)

Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 834,883,264
  • Shares Outstanding, K 950,405
  • Annual Sales, $ 34,124 M
  • Annual Income, $ 5,240 M
  • 60-Month Beta 0.36
  • Price/Sales 24.47
  • Price/Cash Flow 115.82
  • Price/Book 65.09
Trade LLY with:

Options Overview Details

View History
  • Implied Volatility 23.32% ( -0.60%)
  • Historical Volatility 22.06%
  • IV Percentile 16%
  • IV Rank 21.94%
  • IV High 38.67% on 10/26/23
  • IV Low 19.01% on 09/01/23
  • Put/Call Vol Ratio 0.74
  • Today's Volume 28,607
  • Volume Avg (30-Day) 33,642
  • Put/Call OI Ratio 0.97
  • Today's Open Interest 290,181
  • Open Int (30-Day) 264,098

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 21 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate 2.65
  • Number of Estimates 9
  • High Estimate 2.95
  • Low Estimate 2.28
  • Prior Year 2.11
  • Growth Rate Est. (year over year) +25.59%

Price Performance

See More
Period Period Low Period High Performance
1-Month
763.10 +15.12%
on 05/15/24
885.06 -0.75%
on 06/13/24
+114.47 (+14.98%)
since 05/14/24
3-Month
718.30 +22.30%
on 04/25/24
885.06 -0.75%
on 06/13/24
+117.72 (+15.47%)
since 03/14/24
52-Week
434.34 +102.25%
on 07/13/23
885.06 -0.75%
on 06/13/24
+430.73 (+96.21%)
since 06/14/23

Most Recent Stories

More News
Thinking of Buying Madrigal Pharmaceuticals Stock? Eli Lilly Would Like to Have a Word.

Eli Lilly just drizzled on Madrigal Pharmaceuticals' parade.

MDGL : 277.59 (+0.21%)
LLY : 878.45 (-0.55%)
Will Walmart Reach a Trillion-Dollar Market Cap by 2030?

This seemingly unlikely non-tech name quietly deserves to be on the list of contenders that could achieve the feat in the foreseeable future.

AAPL : 212.49 (-0.82%)
MSFT : 442.57 (+0.22%)
TSLA : 178.01 (-2.44%)
WMT : 67.02 (+0.48%)
LLY : 878.45 (-0.55%)
AMZN : 183.66 (-0.09%)
VZIO : 10.70 (+0.38%)
Mounjaro Is Targeting Another Multibillion-Dollar Market: Is Eli Lilly Stock a Buy?

The company has too many weapons at its disposal.

LLY : 878.45 (-0.55%)
Viking Therapeutics Is Great. Here's Why You Shouldn't Buy It

Just because a stock has amazing growth prospects doesn't mean you should ignore its valuation.

LLY : 878.45 (-0.55%)
VKTX : 52.02 (-0.15%)
Eli Lilly Scores Another Major Win and Lines Up Its Next Blockbuster

The drugmaker continues to make headlines for all the right reasons.

LLY : 878.45 (-0.55%)
3 Growth Stocks You Can Buy Right Now Without Any Hesitation

Want peace of mind about your investments? Consider these great stocks.

LLY : 878.45 (-0.55%)
NVO : 142.50 (+0.01%)
VRTX : 480.73 (+0.35%)
This Warren Buffett Stock is the Newest GLP-1 Weight-Loss Contender

Amid rising demand for weight management drugs, this Warren Buffett stock is the newest entry.

NVO : 142.50 (+0.01%)
LLY : 878.45 (-0.55%)
COST : 855.67 (+1.15%)
HIMS : 23.75 (-2.54%)
KR : 50.38 (-0.28%)
BRK.A : 610,900.00 (-0.10%)
BRK.B : 405.54 (-0.09%)
XRT : 74.79 (-1.40%)
WMT : 67.02 (+0.48%)
Wegovy's Precarious Position: 3 Drugs Most Likely to Dethrone Novo Nordisk's Blockbuster Obesity Drug

Novo Nordisk's competition in the obesity drug market is heating up.

NVO : 142.50 (+0.01%)
LLY : 878.45 (-0.55%)
VKTX : 52.02 (-0.15%)
Weight Loss Drugs: Are They Really Magic?

Talking about weight and weight loss with Johann Hari, an Ozempic user and the author of "Magic Pill: The Extraordinary Benefits and Disturbing Risks of the New Weight-Loss Drugs."

NVO : 142.50 (+0.01%)
LLY : 878.45 (-0.55%)
Want to Get Richer? 2 Top Stocks to Buy Now and Hold Forever.

These proven wealth builders have what it takes to deliver solid gains long-term.

BRK.AX : 0.011 (unch)
BRK.A : 610,900.00 (-0.10%)
BRK.B : 405.54 (-0.09%)
AAPL : 212.49 (-0.82%)
KO : 62.55 (+0.07%)
OXY : 59.84 (+0.07%)
BRK-A : N/A (N/A)
BRK-B : N/A (N/A)
LLY : 878.45 (-0.55%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Business Summary

Eli Lilly and Company, one of the world's largest pharmaceutical companies, boasts a diversified product profile including a solid lineup of new successful drugs. It also has a dependable pipeline as it navigates through challenges like patent expirations of several drugs and rising pricing pressure...

See More

Key Turning Points

3rd Resistance Point 891.98
2nd Resistance Point 888.30
1st Resistance Point 883.37
Last Price 878.45
1st Support Level 874.76
2nd Support Level 871.08
3rd Support Level 866.15

See More

52-Week High 885.06
Last Price 878.45
Fibonacci 61.8% 712.88
Fibonacci 50% 659.70
Fibonacci 38.2% 606.52
52-Week Low 434.34

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar